C-Path Welcomes Alphabet Clinical Policy and Strategy Head, Former FDA Commissioner to Board

Retrieved on: 2021-05-19 19:52:30

Tags for this article:

Health sciences

Life Sciences

Health

Critical Path Institute

Drug discovery

Pharmaceutical industry

Food and Drug Administration

PATH

National Academy of Medicine

Clinical and Translational Science Award

Duke University School of Medicine

National Institutes of Health

Click the tags to see associated articles and topics

C-Path Welcomes Alphabet Clinical Policy and Strategy Head, Former FDA Commissioner to Board. View article details on HISWAI: https://www.prnewswire.com/news-releases/c-path-welcomes-alphabet-clinical-policy-and-strategy-head-former-fda-commissioner-to-board-301295366.html

Excerpt

A nationally and internationally recognized expert in cardiovascular medicine, health outcomes research, health care quality and clinical research, Dr.

Article found on: www.prnewswire.com

View Original Article